Cardiovascular Application Market Overview
The global Cardiovascular Application market is expected to rise at a significant rate in the forecast period. The need for cardiovascular devices has increased significantly in recent years. According to World Health Organization, Cardiovascular diseases (CVDs) are the leading cause of death globally. An estimated 17.9 million people died from CVDs in 2023, representing 32% of all global deaths.
Important factors such as the growing old age population across the world, and the increasing prevalence of cardiovascular diseases are boosting the growth of the global Cardiovascular Application market. The favorable reimbursement is another key factor that escalates the growth of the cardiovascular application market. In addition to this, favorable reimbursement policies will minimize the financial burden and will significantly drive the growth of the market.
On the negative side, the market's expansion may be hampered by strict regulatory standards. All commercial pharmaceutical manufacture is regulated by the federal Food and Drug Administration (FDA). Cardiovascular device manufacturers must adhere to FDA guidelines and follow all regulations and procedures connected to the production of these devices.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Device, End User, and Region |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Abbott, General Electric Company, Medtronic, Boston Scientific Corporation, KONINKLIJKE PHILIPS N.V., Terumo, Stryker Corporation, Edwards Lifesciences, Allergan Inc., Smith & Nephew plc, CR Bard Inc., Sonova Holdings, and Dragerwerk AG & Co. KGa. |
Covid-19 Impact on Cardiovascular Application Market
In addition, the current Cardiovascular Application Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Cardiovascular Application Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Cardiovascular Application Market Segment Overview
Based on the Device, the Implantable Cardioverter Defibrillator (ICDs) is the largest sub-segment in the global Cardiovascular Application market. In patients with known, prolonged ventricular tachycardia or fibrillation, ICDs can help prevent sudden death. ICDs have been shown in studies to help avoid cardiac arrest in high-risk patients who haven't developed ventricular arrhythmias but are at risk for them. ICDs from the latest generation may have a dual function, including the capacity to act as a pacemaker. If the heart rate is judged to be too sluggish, the pacemaker feature will stimulate the heart to beat.
Cardiovascular Application Market, By Device
- Cardiac Monitors
- Resting ECG
- ECG Monitors
- Holter Monitors
- Implantable loop Recorder
- Cardiac Pacemaker
- Implantable Cardiac Pacemaker
- External Cardiac Pacemaker
- Cardiac Defibrillators
- Implantable Cardioverter Defibrillator
- External Defibrillator
- Others
Cardiovascular Application Market, By End User
· Hospitals & Clinics
· Cardiac Care Centers
· Ambulatory Centers & Home Care
· Academic Institutes
· Others
Cardiovascular Application Market Regional Overview
In terms of region, North America currently holds the largest share of the global Cardiovascular Application market, and it is expected to continue to do so over the forecast period. Increased prevalence of cardiovascular disease, well-established healthcare infrastructure, and increased public awareness about health are some of the important factors driving the market's rise in this region. Similarly, the Asia Pacific market is expected to grow at the quickest rate in the approaching years. Key factors such as the increasing healthcare industry, rising government attempts to provide better healthcare facilities to citizens, and rising public awareness about disease and treatment are all contributing to the region's market growth.
Cardiovascular Application Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Cardiovascular Application Market, Key Players
· Abbott
· General Electric Company
· Medtronic
· Boston Scientific Corporation
· KONINKLIJKE PHILIPS N.V.
· Terumo
· Stryker Corporation
· Edwards Lifesciences
· Allergan Inc.
· Smith & Nephew plc
· CR Bard Inc.
· Sonova Holdings
· Dragerwerk AG & Co. KGa.
Frequently Asked Questions (FAQ) :
Q1. What is the total CAGR expected to be recorded for the Cardiovascular Application market during the forecast period?
The Cardiovascular Application market is expected to record a CAGR of ~ 7 % during the forecast period.
Q2. What are the driving factors for the Cardiovascular Application market?
- The growing old age population across the world, and the increasing prevalence of cardiovascular diseases, are some significant factors that boost the growth of the Cardiovascular Application market.
Q3. What are the restraining factors for the Cardiovascular Application market?
The strict regulatory standards are anticipated to restrain the growth of the Cardiovascular Application Market.
Q4. Which segment is projected to hold the largest share in the Cardiovascular Application Market?
The Implantable Cardioverter Defibrillator (ICDs) segment is projected to hold the largest share in the Cardiovascular Application Market.
Q5. Which are the prominent players in the Cardiovascular Application Market?
Abbott, General Electric Company, Medtronic, Boston Scientific Corporation, KONINKLIJKE PHILIPS N.V., Terumo, Stryker Corporation, Edwards Lifesciences, Allergan Inc., Smith & Nephew plc, CR Bard Inc., Sonova Holdings, and Dragerwerk AG & Co. KGa. are some key players in the Cardiovascular Application Market
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Cardiovascular Application Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Device
- 5.2.1. Cardiac Monitors
- 5.2.1.1. Resting ECG
- 5.2.1.2. ECG Monitors
- 5.2.1.3. Holter Monitors
- 5.2.1.4. Implantable loop Recorder
- 5.2.2. Cardiac Pacemaker
- 5.2.2.1. Implantable Cardiac Pacemaker
- 5.2.2.2. External Cardiac Pacemaker
- 5.2.3. Cardiac Defibrillators
- 5.2.3.1. Implantable Cardioverter Defibrillator
- 5.2.3.2. External Defibrillator
- 5.2.4. Others
- 5.2.1. Cardiac Monitors
- 5.3. Market Analysis, Insights and Forecast – By End User
- 5.3.1. Hospitals & Clinics
- 5.3.2. Cardiac Care Centers
- 5.3.3. Ambulatory Centers & Home Care
- 5.3.4. Academic Institutes
- 5.3.5. Others
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America, Middle East and Africa
6. North America Cardiovascular Application Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Device
- 6.2.1. Cardiac Monitors
- 6.2.1.1. Resting ECG
- 6.2.1.2. ECG Monitors
- 6.2.1.3. Holter Monitors
- 6.2.1.4. Implantable loop Recorder
- 6.2.2. Cardiac Pacemaker
- 6.2.2.1. Implantable Cardiac Pacemaker
- 6.2.2.2. External Cardiac Pacemaker
- 6.2.3. Cardiac Defibrillators
- 6.2.3.1. Implantable Cardioverter Defibrillator
- 6.2.3.2. External Defibrillator
- 6.2.4. Others
- 6.2.1. Cardiac Monitors
- 6.3. Market Analysis, Insights and Forecast – By End User
- 6.3.1. Hospitals & Clinics
- 6.3.2. Cardiac Care Centers
- 6.3.3. Ambulatory Centers & Home Care
- 6.3.4. Academic Institutes
- 6.3.5. Others
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Cardiovascular Application Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Device
- 7.2.1. Cardiac Monitors
- 7.2.1.1. Resting ECG
- 7.2.1.2. ECG Monitors
- 7.2.1.3. Holter Monitors
- 7.2.1.4. Implantable loop Recorder
- 7.2.2. Cardiac Pacemaker
- 7.2.2.1. Implantable Cardiac Pacemaker
- 7.2.2.2. External Cardiac Pacemaker
- 7.2.3. Cardiac Defibrillators
- 7.2.3.1. Implantable Cardioverter Defibrillator
- 7.2.3.2. External Defibrillator
- 7.2.4. Others
- 7.2.1. Cardiac Monitors
- 7.3. Market Analysis, Insights and Forecast – By End User
- 7.3.1. Hospitals & Clinics
- 7.3.2. Cardiac Care Centers
- 7.3.3. Ambulatory Centers & Home Care
- 7.3.4. Academic Institutes
- 7.3.5. Others
- 7.4. Market Analysis, Insights and Forecast – By Country
- 7.4.1. UK
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Russia
- 7.4.7. Rest of Europe
8. Asia Pacific Cardiovascular Application Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Device
- 8.2.1. Cardiac Monitors
- 8.2.1.1. Resting ECG
- 8.2.1.2. ECG Monitors
- 8.2.1.3. Holter Monitors
- 8.2.1.4. Implantable loop Recorder
- 8.2.2. Cardiac Pacemaker
- 8.2.2.1. Implantable Cardiac Pacemaker
- 8.2.2.2. External Cardiac Pacemaker
- 8.2.3. Cardiac Defibrillators
- 8.2.3.1. Implantable Cardioverter Defibrillator
- 8.2.3.2. External Defibrillator
- 8.2.4. Others
- 8.2.1. Cardiac Monitors
- 8.3. Market Analysis, Insights and Forecast – By End User
- 8.3.1. Hospitals & Clinics
- 8.3.2. Cardiac Care Centers
- 8.3.3. Ambulatory Centers & Home Care
- 8.3.4. Academic Institutes
- 8.3.5. Others
- 8.4. Market Analysis, Insights and Forecast – By Country
- 8.4.1. China
- 8.4.2. India
- 8.4.3. Japan
- 8.4.4. Australia
- 8.4.5. South East Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Cardiovascular Application Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Device
- 9.2.1. Cardiac Monitors
- 9.2.1.1. Resting ECG
- 9.2.1.2. ECG Monitors
- 9.2.1.3. Holter Monitors
- 9.2.1.4. Implantable loop Recorder
- 9.2.2. Cardiac Pacemaker
- 9.2.2.1. Implantable Cardiac Pacemaker
- 9.2.2.2. External Cardiac Pacemaker
- 9.2.3. Cardiac Defibrillators
- 9.2.3.1. Implantable Cardioverter Defibrillator
- 9.2.3.2. External Defibrillator
- 9.2.4. Others
- 9.2.1. Cardiac Monitors
- 9.3. Market Analysis, Insights and Forecast – By End User
- 9.3.1. Hospitals & Clinics
- 9.3.2. Cardiac Care Centers
- 9.3.3. Ambulatory Centers & Home Care
- 9.3.4. Academic Institutes
- 9.3.5. Others
- 9.4. Market Analysis, Insights and Forecast – By Country
- 9.4.1. Brazil
- 9.4.2. Saudi Arabia
- 9.4.3. UAE
- 9.4.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Abbott
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. General Electric Company
- 10.6. Medtronic
- 10.7. Boston Scientific Corporation
- 10.8. KONINKLIJKE PHILIPS N.V.
- 10.9. Terumo
- 10.10. Stryker Corporation
- 10.11. Edwards Lifesciences
- 10.12. Allergan Inc.
- 10.13. Smith & Nephew plc
- 10.14. CR Bard Inc.
- 10.15. Sonova Holdings
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
